Obesity, Appetite Control & Diabetes
Obesity, Appetite Control & Diabetes(肥胖，食欲控制 & 糖尿病)
Obesity, Appetite Control & Diabetes
Satiety, appetite, and craving are CNS drives, whereas metabolism and energy utilization are peripheral endocrine actions.
Stephen M. Stahl, M.D., Ph.D. read more
Obesity, Appetite Control & Diabetes 相关产品(350)
- GC44598Peptide YY (human) (trifluoroacetate salt)纯度: >95.00%
Peptide YY (human) (trifluoroacetate salt)是由肠道L细胞分泌的一种肽类激素。
- GC44895Sitagliptin N-Sulfate (sodium salt)CAS: 2470126-25-9纯度: >95.00%
A metabolite of (–)-sitagliptin
- GC45144Vildagliptin carboxylic acid metabolite (trifluoroacetate salt)CAS: 565453-41-0纯度: >98.00%
A major metabolite of vildagliptin
- GC45252(-)-Sitagliptin Carbamoyl GlucuronideCAS: 940002-59-5纯度: >90.00%
A minor phase II metabolite of (–)-sitagliptin
- GC453151-Palmitoyl-d9-2,3-Dipalmitoyl-sn-glycerolCAS: 2738376-70-8纯度: >99.00%
An internal standard for the quantification of 1,2,3-tripalmitoyl-rac-glycerol
- GC45379Alloxan (hydrate)CAS: 2244-11-3纯度: >98.00%
A toxin that selectively eliminates pancreatic β-cells
- GC45589Urocortin III (human) (trifluoroacetate salt)CAS: 357952-09-1纯度: >95.00%
A neuropeptide hormone
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC44544 | Palmitoleic Acid (sodium salt) | 6610-24-8 | >95.00% | |
An ω-7 monounsaturated fatty acid | ||||
| GC44598 | Peptide YY (human) (trifluoroacetate salt) | - | >95.00% | |
Peptide YY (human) (trifluoroacetate salt)是由肠道L细胞分泌的一种肽类激素。 | ||||
| GC44645 | Pioglitazone (potassium salt) | 1266523-09-4 | >98.00% | |
A PPARγ agonist | ||||
| GC44660 | Platensimycin | 835876-32-9 | >95.00% | |
A selective inhibitor of fatty acid biosynthesis | ||||
| GC44775 | PTP1B Inhibitor | 765317-72-4 | >98.00% | |
A cell-permeable allosteric inhibitor of PTP1B | ||||
| GC44811 | Remogliflozin etabonate | 442201-24-3 | >99.00% | |
A prodrug form of remogliflozin A | ||||
| GC44851 | Rosiglitazone (potassium salt) | 316371-84-3 | >98.00% | |
A PPARγ agonist | ||||
| GC44895 | Sitagliptin N-Sulfate (sodium salt) | 2470126-25-9 | >95.00% | |
A metabolite of (–)-sitagliptin | ||||
| GC44914 | Somatostatin-14 (acetate) | 54472-66-1 | >98.00% | |
A cyclic peptide hormone | ||||
| GC44954 | Stevioside (hydrate) | - | >95.00% | |
A natural non-caloric sweetener | ||||
| GC45139 | Vapreotide (trifluoroacetate salt) | - | >95.00% | |
A peptide NK 1 receptor antagonist | ||||
| GC45144 | Vildagliptin carboxylic acid metabolite (trifluoroacetate salt) | 565453-41-0 | >98.00% | |
A major metabolite of vildagliptin | ||||
| GC45164 | WWL229 | 1338575-28-2 | >98.00% | |
A selective inhibitor of Ces3 | ||||
| GC45186 | ZLN005 (hydrochloride) | - | >98.00% | |
A small molecule activator of PGC-1α expression | ||||
| GC45252 | (-)-Sitagliptin Carbamoyl Glucuronide | 940002-59-5 | >90.00% | |
A minor phase II metabolite of (–)-sitagliptin | ||||
| GC45277 | (±)-Camphene | 79-92-5 | 97.00% | |
| ||||
| GC45315 | 1-Palmitoyl-d9-2,3-Dipalmitoyl-sn-glycerol | 2738376-70-8 | >99.00% | |
An internal standard for the quantification of 1,2,3-tripalmitoyl-rac-glycerol | ||||
| GC45320 | 1-Stearoyl-3-Oleoyl-rac-glycerol | 18266-27-8 | >98.00% | |
A diacylglycerol | ||||
| GC45379 | Alloxan (hydrate) | 2244-11-3 | >98.00% | |
A toxin that selectively eliminates pancreatic β-cells | ||||
| GC45490 | Kisspeptin-54 (human) (trifluoroacetate salt) | - | >95.00% | |
A peptide ligand of GPR54 | ||||
| GC45506 | MD001 | 2254605-76-8 | >90.00% | |
A dual agonist of PPARα and PPARγ | ||||
| GC45567 | SR 1903 | 1414248-06-8 | >98.00% | |
A modulator of RORγ and LXR receptors | ||||
| GC45589 | Urocortin III (human) (trifluoroacetate salt) | 357952-09-1 | >95.00% | |
A neuropeptide hormone | ||||
| GC45590 | Urocortin III (mouse) (free acid) (trifluoroacetate salt) | - | >95.00% | |
| ||||